EUVIMEDEUVIMED entdecken
Crossref

MET overexpression correlated with prognosis of EGFR-mutant treatment‑naïve advanced lung adenocarcinoma: a real‑world retrospective study

Na Wang, Yuan Zhang, Junhua Wu, Yili Zhu, Ying Wu, Bo Huang, Ruiguang Zhang, Jun Fan, Xiu Nie

Clinical and Translational Oncology · 2024

DOI: 10.1007/s12094-024-03391-x ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical and Translational Oncology, 2024. Verfasst von Na Wang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1277 Jiefang Avenue, Wuhan, Hubei, Ch…. Hauptthemen laut MEDLINE: Proto-Oncogene Proteins c-met, ErbB Receptors, Lung Neoplasms, Mutation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 29 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Hubei Province, Key Technologies Research and Development Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Proto-Oncogene Proteins c-metErbB ReceptorsLung NeoplasmsMutationAdenocarcinoma of LungHumansMaleRetrospective StudiesFemaleMiddle AgedPrognosisAgedAdultAged, 80 and overProgression-Free SurvivalEpithelial-Mesenchymal Transition

Stichwörter der Autor:innen

Advanced lung adenocarcinomaEGFR mutationEGFR–TKIL858RMET expressionPrognosis

Substanzen

Proto-Oncogene Proteins c-metErbB ReceptorsMET protein, humanEGFR protein, human

Autor:innen und Institutionen

  • Department of Pathology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1277 Jiefang Avenue, Wuhan, Hubei, China.
  • Department of Obstetrics and Gynecology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, Hubei, China.
  • Department of Pathology, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, 510630, China.
  • Department of Pathology, Xiangyang Central Hospital, Affiliated Hospital of Hubei University of Arts and Science, Xiangyang, 441000, Hubei, China.
  • Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, Hubei, China.
  • Department of Pathology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1277 Jiefang Avenue, Wuhan, Hubei, China. fanjun0915@sina.com.

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Hubei Province
  • Key Technologies Research and Development Program

Zitieren

APA

Wang, N., Zhang, Y., Wu, J., Zhu, Y., Wu, Y., Huang, B., Zhang, R., Fan, J., & Nie, X. (2024). MET overexpression correlated with prognosis of EGFR-mutant treatment‑naïve advanced lung adenocarcinoma: a real‑world retrospective study. Clinical and Translational Oncology. https://doi.org/10.1007/s12094-024-03391-x

Vancouver

Wang N, Zhang Y, Wu J, Zhu Y, Wu Y, Huang B, et al. MET overexpression correlated with prognosis of EGFR-mutant treatment‑naïve advanced lung adenocarcinoma: a real‑world retrospective study. Clinical and Translational Oncology. 2024. doi:10.1007/s12094-024-03391-x

BibTeX
@article{Wang2024,
  author = {Wang, Na and Zhang, Yuan and Wu, Junhua and Zhu, Yili and Wu, Ying and Huang, Bo and Zhang, Ruiguang and Fan, Jun and Nie, Xiu},
  title = {MET overexpression correlated with prognosis of EGFR-mutant treatment‑naïve advanced lung adenocarcinoma: a real‑world retrospective study},
  journal = {Clinical and Translational Oncology},
  year = {2024},
  doi = {10.1007/s12094-024-03391-x}
}
Kostenlos starten →